MedPath

se of the corifolitropina alfa in oocyte donors

Conditions
The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program
Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
Registration Number
EUCTR2014-001743-20-ES
Lead Sponsor
IVI Madrid
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Women aged 18-35 years who meet the entry criteria for the IVI Donor Program and will be receiving stimulation with gonadotropins.
- Weight <60 kg
- Women with at least 6 antral follicles per ovary
- Will to fit the protocol during the study period
- Woman who gives written consent to participate in Test
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 300
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Woman with a basal antral follicle count above 20 or below 6
- Women with comorbidities, in the judgment of the investigator, that may interfere with the treatment of ovarian stimulation

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath